Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

jueves, 26 de marzo de 2026, 8:17 am ET1 min de lectura
ATOS--

Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

Atossa Therapeutics: Wainwright Raises Buy Rating to $25 from $7

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios